Micardis and Eye irritation - a phase IV clinical study of FDA data
Summary:
Eye irritation is reported as a side effect among people who take Micardis (telmisartan), especially for people who are female, 60+ old, also take Crestor, and have Diabetes.
The phase IV clinical study analyzes which people have Eye irritation when taking Micardis. It is created by eHealthMe based on reports of 26,556 people who have side effects when taking Micardis from the FDA, and is updated regularly.
What is Micardis?
Micardis has active ingredients of telmisartan. It is often used in high blood pressure. eHealthMe is studying from 27,605 Micardis users. Check the latest studies of Micardis.
What is Eye irritation?
Eye irritation is found to be associated with 1,296 drugs and 1,287 conditions by eHealthMe. Check the latest studies of Eye irritation.
26,556 people reported to have side effects when taking Micardis.
Among them, 19 people (0.07%) have Eye irritation.

Among these 19 people:
What is the gender of people who have Eye irritation when taking Micardis? *
- female: 55.56 %
- male: 44.44 %
What is the age of people who have Eye irritation when taking Micardis? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 12.5 %
- 50-59: 0.0 %
- 60+: 87.5 %
What are other drugs people take besides Micardis? *
- Crestor: 3 people, 15.79%
- Spiriva: 2 people, 10.53%
- Metformin: 2 people, 10.53%
- Amlodipine: 2 people, 10.53%
- Aspirin: 2 people, 10.53%
- Levitra: 2 people, 10.53%
- Biotin: 2 people, 10.53%
- Zyrtec: 1 person, 5.26%
- Gleevec: 1 person, 5.26%
- Hydrochlorothiazide: 1 person, 5.26%
What are other side effects people have besides Eye irritation? *
- Vision Blurred: 4 people, 21.05%
- Ocular Hyperaemia (an abnormally large amount of blood in eye): 3 people, 15.79%
- Hypoaesthesia (reduced sense of touch or sensation): 3 people, 15.79%
- Dizziness: 3 people, 15.79%
- Eye Swelling: 3 people, 15.79%
- Indigestion: 2 people, 10.53%
- Dyspnea (difficult or laboured breathing): 2 people, 10.53%
- Pain: 2 people, 10.53%
- Muscle Spasms (muscle contraction): 2 people, 10.53%
- Headache (pain in head): 2 people, 10.53%
What are the existing conditions these people have? *
- Arterial Occlusive Disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked): 2 people, 10.53%
- Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 2 people, 10.53%
- Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 10.53%
- Diabetes: 2 people, 10.53%
- Dry Eyes (lack of adequate tears): 1 person, 5.26%
- Asthma: 1 person, 5.26%
- Bipolar Disorder (mood disorder): 1 person, 5.26%
- Cardiac Failure: 1 person, 5.26%
- Colon Cancer: 1 person, 5.26%
- Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 5.26%
* Approximation only. Some reports may have incomplete information.
Do you take Micardis and have Eye irritation?
- Check whether Eye irritation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Micardis:
- Micardis (27,605 reports)
Eye irritation treatments and more:
- Eye irritation (50,674 reports)
How severe was Eye irritation and when was it recovered:
Expand to all the drugs that have ingredients of telmisartan:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Micardis:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Eye irritation:
- Eye irritation (1,296 drugs)
Browse all the conditions that are associated with Eye irritation:
- Eye irritation (1,287 conditions)
Related publications that referenced our studies
- Kato Y, Mukai Y, Rane A, Inotsume N, Toda T, "The inhibitory effect of telmisartan on the metabolism of arachidonic acid by CYP2C9 and CYP2C8: an in vitro study", Biological and Pharmaceutical Bulletin, 2017 Sep .
- Kim HK, Youm JB, Lee SR, Lim SE, Lee SY, Ko TH, Nilius B, Noh JH, Ko KS, Rhee BD, Kim N, "The angiotensin receptor blocker and PPAR-γ agonist, telmisartan, delays inactivation of voltage-gated sodium channel in rat heart: novel mechanism of drug action", Pflügers Archiv-European Journal of Physiology, 2012 Dec .
- Kato Y, Mukai Y, Rane A, Inotsume N, Toda T, "The inhibitory effect of telmisartan on the metabolism of arachidonic acid by CYP2C9 and CYP2C8: an in vitro study", Biological and Pharmaceutical Bulletin, 2017 Sep .
- Kim HK, Youm JB, Lee SR, Lim SE, Lee SY, Ko TH, Nilius B, Noh JH, Ko KS, Rhee BD, Kim N, "The angiotensin receptor blocker and PPAR-γ agonist, telmisartan, delays inactivation of voltage-gated sodium channel in rat heart: novel mechanism of drug action", Pflügers Archiv-European Journal of Physiology, 2012 Dec .
How the study uses the data?
The study uses data from the FDA. It is based on telmisartan (the active ingredients of Micardis) and Micardis (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Sudafed cause Secretion Discharge? - 10 seconds ago
- Trandate vs. Twynsta, side effect and effectiveness comparison - 11 seconds ago
- Could Claritin Reditabs cause Sinusitis - Acute? - 16 seconds ago
- Could Claritin Reditabs cause Sinusitis? - 17 seconds ago
- Thyroid Hormone Replacement Therapy and Gait Disturbance - 19 seconds ago
- Drug interactions of Metoprolol Tartrate and Prozac - 19 seconds ago
- Could Albuterol cause Multiple Drug Overdose Intentional? - 42 seconds ago
- Could Morphine cause Apathy? - 53 seconds ago
- Drug interactions of Paracetamol and Fragmin - 55 seconds ago
- Drug interactions of Dupixent and Amphetamine - 56 seconds ago